Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
64.3M
-
Number of holders
-
176
-
Total 13F shares, excl. options
-
62.9M
-
Shares change
-
-61.3K
-
Total reported value, excl. options
-
$1.51B
-
Value change
-
-$90M
-
Put/Call ratio
-
0.27
-
Number of buys
-
101
-
Number of sells
-
-78
-
Price
-
$24.02
Significant Holders of Vera Therapeutics, Inc. - COMMON STOCK (VERA) as of Q1 2025
218 filings reported holding VERA - Vera Therapeutics, Inc. - COMMON STOCK as of Q1 2025.
Vera Therapeutics, Inc. - COMMON STOCK (VERA) has 176 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 62.9M shares
of 64.3M outstanding shares and own 97.81% of the company stock.
Largest 10 shareholders include Avoro Capital Advisors LLC (5.7M shares), PRICE T ROWE ASSOCIATES INC /MD/ (4.75M shares), BlackRock, Inc. (3.99M shares), FMR LLC (3.23M shares), VANGUARD GROUP INC (2.92M shares), Sofinnova Investments, Inc. (2.79M shares), COMMODORE CAPITAL LP (2.56M shares), Vestal Point Capital, LP (2.5M shares), Kynam Capital Management, LP (2.4M shares), and Holocene Advisors, LP (2.2M shares).
This table shows the top 176 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.